MED
Medifast·NYSE
--
--(--)
--
--(--)
5.03 / 10
Netural
Fund flow evaluation: 7.97/10 reflecting robust fund flow characteristics. Constructive overall, block, Small, Large, and Extra-large trends face headwinds from adverse Medium developments, indicating positive money flow direction. Professional analyst opinion suggests divided analyst consensus, showing neutral perspective. Distribution pattern: Neutral(100.0%) based on 1 research evaluations, supported by 2.08 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-02-19
InstitutionDA Davidson
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for MED?
- MED holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.03/10 (Netural).
